Brighten Optix Financials
| 6747 Stock | TWD 133.50 2.50 1.84% |
Brighten |
Understanding current and past Brighten Optix Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Brighten Optix's financial statements are interrelated, with each one affecting the others. For example, an increase in Brighten Optix's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Brighten Optix's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Brighten Optix. Check Brighten Optix's Beneish M Score to see the likelihood of Brighten Optix's management manipulating its earnings.
Brighten Optix Stock Summary
Brighten Optix competes with Universal Vision, Excelsior Medical, Delta Asia, Hi Clearance, and Brighten Optix. Brighten Optix Corporation researches and develops, manufactures, and sells specialty contact lenses in Taiwan and the Asia Pacific region. The company offers its products under the Ortho-K myopia management lens, HiClear gas permeable lens, Briomoist lens care systems, SynergEyes hybrid lens, and Large Diameter GP lens. BRIGHTEN OPTIX operates under Medical Devices classification in Taiwan and is traded on Taiwan OTC Exchange.| Instrument | Taiwan Stock View All |
| Exchange | Taiwan OTC Exchange |
| Business Address | No150, Chengde Road, |
| Sector | Healthcare |
| Industry | Medical Devices |
| Benchmark | Dow Jones Industrial |
| Website | www.brightenoptix.com.tw |
| Phone | 886 2 2880 1778 |
| Currency | TWD - New Taiwan Dollar |
You should never invest in Brighten Optix without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Brighten Stock, because this is throwing your money away. Analyzing the key information contained in Brighten Optix's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Brighten Optix Key Financial Ratios
There are many critical financial ratios that Brighten Optix's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Brighten Optix reports annually and quarterly.| Return On Equity | 0.22 | |||
| Return On Asset | 0.12 | |||
| Target Price | 255.0 | |||
| Beta | 0.37 | |||
| Last Dividend Paid | 8.68 |
Brighten Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Brighten Optix's current stock value. Our valuation model uses many indicators to compare Brighten Optix value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Brighten Optix competition to find correlations between indicators driving Brighten Optix's intrinsic value. More Info.Brighten Optix is rated second in return on equity category among its peers. It also is rated second in return on asset category among its peers reporting about 0.55 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Brighten Optix is roughly 1.83 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Brighten Optix's earnings, one of the primary drivers of an investment's value.Brighten Optix Systematic Risk
Brighten Optix's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Brighten Optix volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was fourteen with a total number of output elements of fourty-seven. The Beta measures systematic risk based on how returns on Brighten Optix correlated with the market. If Beta is less than 0 Brighten Optix generally moves in the opposite direction as compared to the market. If Brighten Optix Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Brighten Optix is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Brighten Optix is generally in the same direction as the market. If Beta > 1 Brighten Optix moves generally in the same direction as, but more than the movement of the benchmark.
Brighten Optix November 28, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Brighten Optix help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Brighten Optix. We use our internally-developed statistical techniques to arrive at the intrinsic value of Brighten Optix based on widely used predictive technical indicators. In general, we focus on analyzing Brighten Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Brighten Optix's daily price indicators and compare them against related drivers.
| Information Ratio | (0.30) | |||
| Maximum Drawdown | 4.35 | |||
| Value At Risk | (1.63) | |||
| Potential Upside | 1.32 |
Additional Tools for Brighten Stock Analysis
When running Brighten Optix's price analysis, check to measure Brighten Optix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Brighten Optix is operating at the current time. Most of Brighten Optix's value examination focuses on studying past and present price action to predict the probability of Brighten Optix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Brighten Optix's price. Additionally, you may evaluate how the addition of Brighten Optix to your portfolios can decrease your overall portfolio volatility.